Discordant expression of Ii and HLA-DR in thyrocytes: A possible pathogenetic factor in Hashimoto's thyroiditis

被引:5
|
作者
Yu, MJ
Xu, MZ
Savas, L
Khan, A
机构
[1] Univ Massachusetts, Med Ctr, Dept Pathol, Worcester, MA 01655 USA
[2] Antigen Express Inc, Worcester, MA USA
关键词
Hashimoto's thyroiditis; HLA-DR; invariant chain (Ii); autoimmune disease; autoantigen;
D O I
10.1007/BF02739959
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hashimoto's thyroiditis is the archetype of organ-specific autoimmune disease. The key pathogenetic feature is the activation of thyroid-specific T-cells by properly presented endogenous thyroid antigens. There is strong indication that thyrocytes themselves present self-antigens, based on the finding of antigen presenting human leukocyte antigen-DR (HLA-DR) molecules on the thyrocytes in Hashimoto's thyroiditis. Because class Ii-associated invariant chain (li) is tightly bound to the antigen-binding groove of the DR molecules in the endoplasmic reticulum and is found to compete with the endogenous peptides for binding with DR, it is speculated that ii prevents endogenous peptides from binding to, and being presented by, DR on the cell surface. We hypothesize that in Hashimoto's thyroiditis, ii is insufficient, leaving DR molecules open for endogenous peptides. In this article, we test our hypothesis of discordance between DR and ii in the thyroid epithelial cells in Hashimoto's thyroiditis by immunohistochemistry. Formalin-fixed, paraffin-embedded archival tissue from eight cases of Hashimoto's thyroiditis and four cases of normal thyroid specimen were randomly selected and immunostained with monoclonal antibodies (MAbs) against HLA-DR and ii using avidin-biotin-peroxidase method. We found that in all eight cases of Hashimoto's thyroiditis, ii is significantly reduced relative to DR. The results support our hypothesis that presentation of self-antigen may be a result of insufficient ii in the thyrocytes in Hashimoto's thyroiditis.
引用
收藏
页码:201 / 208
页数:8
相关论文
共 50 条
  • [21] Expression of Class II Human Leukocyte Antigens (HLA-DR and HLA-DQ) on Platelets
    Aufi, Manal
    Greenshields, Anna
    Liwski, Robert
    Quinn, Jason
    TRANSFUSION, 2020, 60 : 112A - 113A
  • [22] HLA-DR expression is a significant prognostic factor in laryngeal cancer - A morphometric study
    Sikorska, B
    Danilewicz, M
    Wagrowska-Danilewicz, M
    APMIS, 1999, 107 (04) : 383 - 388
  • [23] Possible pathogenetic relevance of interleukin-1β in "'destructive" organ-specific autoimmune disease (Hashimoto's thyroiditis)
    Paolieri, F
    Salmaso, C
    Battifora, M
    Montagna, P
    Pesce, G
    Bagnasco, M
    Richiusa, P
    Galluzzo, A
    Giordano, C
    NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES, 1999, 876 : 221 - 228
  • [24] AN INFLUENCE OF HLA-A, B, DR, DQ ON THE OCCURRENCE OF HASHIMOTO'S THYROIDITIS IN CHILDREN WITH TYPE 1 DIABETES
    Lampic, Marusa
    Jamnik, Sabina K.
    Battelino, Tadej
    Vidan-Jeras, Blanka
    TISSUE ANTIGENS, 2013, 81 (05): : 376 - 377
  • [25] IMMUNE-COMPLEXES, LYMPHOCYTE SUBPOPULATIONS AND HLA-DR POSITIVE EPITHELIAL-CELLS IN THYROID-GLANDS FROM PATIENTS WITH HASHIMOTO THYROIDITIS
    AICHINGER, G
    FILL, H
    WICK, G
    ANNALES D ENDOCRINOLOGIE, 1984, 45 (01) : 55 - 55
  • [26] Association of HLA-DR and type II collagen autoimmunity with Meniere's disease
    Koo, JW
    Oh, SH
    Chang, SO
    Park, MH
    Lim, MJ
    Yoo, TJ
    Kim, CS
    TISSUE ANTIGENS, 2003, 61 (01): : 99 - 103
  • [27] HLA-DR Class II expression on myeloid and lymphoid cells in relation to HLA-DRB1 as a genetic risk factor for visceral leishmaniasis
    Singh, Bhawana
    Fakiola, Michaela
    Sudarshan, Medhavi
    Oommen, Joyce
    Singh, Siddharth Sankar
    Sundar, Shyam
    Blackwell, Jenefer M.
    IMMUNOLOGY, 2019, 156 (02) : 174 - 186
  • [28] CLASS-II MHC ANTIGEN (HLA-DR) EXPRESSION IN THE DEVELOPING SWEAT GLAND
    LAMPERT, IA
    EASTY, D
    EVANS, DJ
    TISSUE ANTIGENS, 1986, 28 (05): : 269 - 274
  • [29] Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves’ disease
    A A Zeitlin
    J M Heward
    P R Newby
    J D Carr-Smith
    J A Franklyn
    S C L Gough
    M J Simmonds
    Genes & Immunity, 2008, 9 : 358 - 363
  • [30] Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease
    Zeitlin, A. A.
    Heward, J. M.
    Newby, P. R.
    Carr-Smith, J. D.
    Franklyn, J. A.
    Gough, S. C. L.
    Simmonds, M. J.
    GENES AND IMMUNITY, 2008, 9 (04) : 358 - 363